CT:IQ is pleased to welcome Central Pharmacy Logistics (CPL) Australia as the newest member of our Steering Committee.
CPL is a licenced Direct to Patient Clinical Trials solutions service, supporting the decentralised model of clinical trials. The organisation provides comprehensive project management for each patient—supporting nursing in the home to administer Investigational Medicinal Products and collect biological samples when required.
CPL is also a TGA-licenced facility for primary and secondary manufacturing, warehousing, and global distribution of clinical trial investigational products and supplies. Notably, CPL is Australia’s first depot and pharmacy co-located in one facility, serving both clinical trial patients and sites across Australia and New Zealand.
Their expertise in supporting decentralised trial delivery and patient-centred logistics aligns closely with CT:IQ’s aim to improve the efficiency, quality, and impact of clinical trials in Australia.
We look forward to collaborating with CPL as part of our Steering Committee and drawing on their unique experience in direct-to-patient clinical trial solutions to inform CT:IQ’s projects and initiatives.
